In 2022, Germitec received investments from Financière Arbevel, Kurma Partners, via its Kurma Growth Opportunities fund, and Sham Innovation Santé advised by Turenne Capital, become GERMITEC in preparation for its global commercial launch and to expand into the U.S. market. Germitec has its headquarters in Bordeaux and is building their team for global commercialization and additional pipeline products. Germitec is hiring its Head of Marketing.
We have partnered with Sébastien Lemoine, Chief Business Officer, to hire our Head of Marketing. This position will own upstream and downstream marketing strategies and execution for international markets. This person will support the direct sales and distribution networks while partnering with R&D to bring new products to market.
Germitec UV-C high level disinfection technology is leading the way in chemical free and ultrafast automated high level disinfection for reprocessing ultrasound probes. Our technology works by delivering UV-C High Level Disinfection (HLD) as particles and waves reflected from the chamber walls. Its chemical free operation safeguards staff and patients by avoiding hazardous chemicals, fumes, and spills. When seconds count, Germitec systems, Chronos and AE1, deliver a Faster, Simpler and Cleaner solution that reduces cross-infection risk, for a seamless High Level Disinfection. Thus improving quality patient care.
Company Overview
GERMITEC’s corporate and societal narrative
How Chronos HLD Technology Works
Optimizing scanning workflow with Germitec
Germitec Presentation Video
Lifeblood™ supports global MedTech Startups with Talent Acquisition and Fundraising Strategies. We build full-scale startup teams from Board and C-level executives to entry-level individual contributors and from early-stage R&D through multi-national commercialization phases.Approaching two decades of experience in the MedTech industry, our talent acquisition services and team-building efforts are the results of 2,000+ successful hires for 500+ companies in 6 continents. We have facilitated more than $220 million for MedTech startups with our fundraising strategies and global investor network.
People and money are the lifeblood capital of startups. Learn from our entrepreneurs and investors as we demystify raising and investing capital on our MedTech Money Podcast Series.